PanTera aims to secure the large-scale production of actinium-225 (225Ac), one of the most promising alpha-emitting radioisotopes to fight cancers by Targeted RadioTherapy (TRT). By working towards this large-scale production, PanTera’s ultimate goal is to improve the accessibility of future innovative cancer therapy based on 225Ac and theranostics in general.

PANTERA

This department ensures the quality and compliance of products through systematic testing and quality assurance processes.

Quality Control

This department manages financial planning, reporting, and accounting activities.

Finance Department

This department specializes in the study and application of radiochemical processes and materials.

Radiochemistry Division

This department is responsible for the manufacturing and engineering processes involved in the production of radiopharmaceuticals used in medical applications.

Radiopharmaceuticals Production

This department focuses on innovation and the development of new products and technologies through scientific research and experimentation.

People (4)

Jobs (0)

Other teams

Finance Department

Radiochemistry Division

Radiopharmaceuticals Production

Research and Development